CompletedPhase 4NCT02274662

Expanded Access Protocol Thymus Transplantation

Studying T-cell immunodeficiency with thymic aplasia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sumitomo Pharma Switzerland GmbH
Principal Investigator: John W. Sleasman, M.D., MD
Duke University Medical Center, Pediatrics, Allergy & Immunology
Intervention: Cultured Thymus Tissue(biological)
Enrollment: 11 enrolled
Eligibility: All sexes
Timeline: 2014 – 2023

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02274662 on ClinicalTrials.gov

← Back to all trials